IU Health Goshen Center for Cancer Care

Our Approach to Liver Cancer

Integrated Care for Liver Cancer Patients

At Indiana University Health Goshen Center for Cancer Care, we’ve created a comprehensive liver cancer treatment program committed to your overall health. It’s a commitment that reaches from your initial diagnosis to recovery and beyond.

Throughout treatment, we use an integrated approach to cancer care where physicians, dietitians, naturopathic oncologists and counselors all work together as a team. These specialists bring a number of disciplines – from leading-edge medical therapies and groundbreaking research to patient-specific clinical trials – to offer you the most complete care possible. Plus, you have access to a host of supportive services, including counselors, support groups and chaplains. Every day, this multidisciplinary team of specialists works together to share ideas and contribute to your individualized treatment plan. And in recovery, we teach you to maintain a healthier lifestyle to help prevent cancer from returning.

At IU Health Goshen Center for Cancer Care, we’ve created a place like no other. Working to heal you, not just treat your cancer.

The right treatments

Metastatic cancer to the liver is more prevalent than primary liver cancer. That’s why we offer several aggressive and advanced treatments for all types of liver cancer, used in combination or alone and with naturopathic and alternative medicines.

SIRT technology with microspheres

We are one of the few cancer centers in the country to offer breakthrough selective internal radiation therapy (SIRT) with microspheres, which destroys liver cancer from the inside out and improves treatment outcomes.

TomoTherapy radiation

As one of a few in the nation to offer TomoTherapy®, we can treat tumors that were once untreatable. TomoTherapy uses small, focused radiation beams directed at the tumor from thousands of positions, while sparing nearby healthy tissue.

About liver cancer

In the past two decades, incidence and mortality rates for liver cancer have increased in all races and both sexes. It is now the fifth most common cancer in men and ninth in women, according to the American Cancer Society. Approximately 22,620 new cases of primary liver and bile duct cancer were diagnosed in the United States in 2009. This cancer is more common in men than in women.

Although the numbers for primary liver cancer are low compared to other types of cancer, the liver is second only to the lymph nodes as the most common site for other cancers to spread in the body. For this reason, metastatic cancer to the liver is more common in the United States than primary liver cancer. Fortunately, new, revolutionary treatments, such as selective internal radiation therapy (SIRT), are available at progressive treatment centers, such as IU Health Goshen Center for Cancer Care to treat metastatic colon cancer to the liver.